Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma

ConclusionThis case evidences that sequential personalized prescription of different TKIs may show promising efficacy in terms of survival and quality of life in MCC.

Source: Experimental Hematology and Oncology - September 6, 2018 Category: Cancer & Oncology Source Type: research